CYLTEZO
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90872925
- Registration number
- 7183729
- Mark type
- Stylized text
- Filed
- 09 Aug 2021
- Published for opposition
- 14 Jun 2022
- Registered
- 03 Oct 2023
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of chronic inflammatory diseases, rheumatoid arthritis, psoriasis and Crohn's disease
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 26 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2023 — USE AMENDMENT FILED
- 09 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 19 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Aug 2022 — SOU EXTENSION 1 GRANTED
- 17 Aug 2022 — SOU EXTENSION 1 FILED
- 17 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jun 2022 — PUBLISHED FOR OPPOSITION